Author: Chris Underdown

AMLAN Internacional Recibe la Patente en China de la Fórmula para la Salud Intestinal.

Posted on | by Chris Underdown

CHICAGO—AMLAN Internacional recibió recientemente la patente en China para sus productos formulados destinados a mejorar la salud intestinal animal. Los productos tienen tres distintivos modos de acción que trabajan juntos para fortalecer el ambiente intestinal del animal.

Las patentes para las mismas fórmulas están pendientes en los EE.UU. y en otros países.” La ciencia y la investigación son los fundamentos de nuestro proceso de desarrollo de nuevas moléculas para mejorar naturalmente el desempeño y a la vez proteger la salud intestinal del animal”, dice Ron Cravens, presidente de AMLAN Internacional, una corporación de Nevada. “El aseguramiento de las patentes en China es una mayor validación de nuestra estrategia de desarrollo y el valor tanto de nuestra investigación como de nuestros productos.”

La patente cubre dos productos especialmente formulados para sus respectivas especies. En la avicultura, Varium mejora la eficiencia alimenticia, promueve el crecimiento y reduce la mortalidad mientras reemplaza o mejora el uso de antibióticos promotores de crecimiento existentes. NeoPrime estimula un ambiente intestinal saludable y entrena al sistema inmune para mejorar el desempeño de lechones en post-destete. Los aditivos de alimento están siendo continuamente probados en el campo, demostrando superioridad ante productos de la competencia lo cual permite permite a los productores maximizar tanto los ingresos como las ganancias.

“Un enfoque emergente en la salud animal son los promotores de crecimiento para el ganado que fortalecen la barrera intestinal para resistir las enfermedades”, dice Cravens. “AMLAN está al frente del desarrollo de soluciones naturales que permiten al animal permiten al animal defenderse naturalmente por si solo al reducir los patógenos intestinales y sus biotoxinas”. En el 2013, el alcance el alcance global de la compañía llegó con el establecimiento de una subsidiaria en Shenzhen, China. Para más información sobre el portafolio de productos Amlan, visite AMLAN.com.

Contacto

Reagan Culbertson (312)702- 3256

Reagan.culbertson@AMLAN.com

Referente a AMLAN Internacional

Parte de la corporación Oil-Dri de América (NYSE: ODC), una empresa de Delaware cuyo nombre comercial es “AMLAN Internacional”, ha aumentado su oferta de productos al desarrollar nuevas moléculas para la salud intestinal, una alternativa de los AGP (antibióticos promotores de crecimiento) del mercado. El laboratorio del departamento de Investigación y Desarrollo está ubicado en Vernon Hills, IL. En el 2013, el alcance global de la compañía se expandió con el establecimiento de su subsidiaria China, en Shenzhen. Para más información sobre AMLAN Internacional, visite AMLAN.com.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Receives Patent in China for Intestinal Health Formulation

Posted on | by Chris Underdown

CHICAGO— Amlan International recently received a patent in China for its formulated intestinal health products. The products have three distinct modes of action that work together to strengthen the intestinal environment of livestock.

Patents for the same formula are currently pending in the United States and additional strategic countries. “Science and research are the foundation of our discovery process to naturally improve animal performance by protecting intestinal health,” says Ron Cravens, President, Amlan International, a Nevada corporation. “The issuance of the patent in China is further validation of our development strategy and the value of both our research and products.”

The patent covers two products specifically formulated for their respective species. In poultry, Varium improves feed efficiency, promotes growth and reduces mortality while replacing or enhancing existing antibiotic growth promoters. NeoPrime stimulates a healthy intestinal environment and primes the immune system for improved post-weaning piglet performance. The feed additives are being continuously proven efficacious in the field by outperforming competitive products and enabling producers to maximize both revenue and profit.

“An emerging focus in animal health is promoting the growth of livestock by strengthening the intestinal barrier to resist disease,” Cravens says. “Amlan is at the forefront of developing natural solutions that allow the animal to naturally defend itself by reducing intestinal pathogens and their biotoxins.” In 2013, the company’s global reach expanded with the establishment of a subsidiary in Shenzhen, China. For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Announces Opening of New Laboratory

Posted on | by Chris Underdown

CHICAGO— Amlan International, a global leader in feed additives that improve intestinal health, today announced the opening of its Richard M. Jaffee Laboratory for Applied Microbiology located at the company’s Innovation Center in Vernon Hills, Illinois. The investment includes advanced microbiologists, research instruments and equipment dedicated to accelerating Amlan’s technical expertise and new product development.

The Company also announced the hiring of two Senior Research Microbiologists, Dongping Wang, Ph.D. and Shalaka Shinde, Ph.D. The new teammates are experienced microbiologists with specialized expertise and will help advance the company’s efforts in Life Sciences research.

The Biosafety Level 2 lab enables the examination of materials, such as animal feed, intestinal tissue and feces, and their interaction with bacteria or fungus. Pathogen identification, biotoxin diagnosis and bacterial strain enumeration can now be achieved with the lab’s technical and diagnostic capabilities such as the analyses of DNA and RNA proteins (PCR), antimicrobial assays (MIC & MBC), cellular and morphological analyses (Optical Microscopy) and tissue culturing.

Dr. Ron Cravens, President of Amlan International, a Nevada corporation, stated “We are excited that the new lab will allow us to further our understanding of how our products support intestinal health from within the microbiota. Additionally, we aspire to leverage our expertise and new tools to collaborate with our customers by offering diagnostic testing and technical support. I am confident that the new lab will allow us to optimize our existing product offerings and take product development to new heights.”

The lab was named after Richard M. Jaffee, Chairman of Amlan’s parent company, Oil-Dri Corporation of America. His pioneering spirit and vision for Oil-Dri to conduct research in life sciences has been influential in the development of Amlan’s value-added animal health products. In addition to the previously discussed initiatives, the lab will be used by all facets of Oil-Dri’s business and its development is an investment in the future of the company as a whole.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

 

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

AMLAN Internacional Anuncia la Apertura de un Nuevo Laboratorio.

Posted on | by Chris Underdown

Chicago—AMLAN Internacional, un líder mundial de aditivos de alimento los que mejoran la salud intestinal hoy anuncia la apertura de su Laboratorio para la Microbiología Aplicada, Richard M. Jaffee, localizado en el Centro de Innovación de la compañía en Vernon Hills, Illinois. La inversión incluye microbiólogos avanzados, instrumental de investigación y equipamiento dedicado a acelerar la experiencia técnica de AMLAN y el desarrollo de nuevos productos.

La compañía también anunció la contratación de dos Microbiólogos Investigadores Senior, Dongping Wang, Ph. D. y Shalaka Shide, Ph. D. Los nuevos compañeros de equipo son microbiólogos experimentados con experiencia especializada y ayudarán a avanzar en el esfuerzo de la compañía en la investigación en Ciencias de la Vida.

El laboratorio de Nivel de Bioseguridad 2 permite el examen de materiales, como el alimento animal, tejidos intestinales y heces, y su interacción con bacterias y hongos. La identificación de patógenos, el diagnóstico de biotoxinas y la enumeración de cepas de bacterias ahora se pueden lograr con el laboratorio técnico y las capacidades diagnósticas como los análisis de ADN y proteínas de ARN (PCR), ensayos antimicrobianos (MIC y MBC), análisis celulares y morfológicos (Microscopía Óptica) y cultivo de tejidos. El Dr. Ron Cravens, presidente de AMLAN Internacional, una corporación de Nevada

declaró “Estamos entusiasmados que el nuevo laboratorio que nos permitirá una mayor comprensión de como nuestros productos apoyan la salud intestinal de la microbiota.  Además, aspiramos a impulsar nuestra experiencia y las nuevas herramientas para colaborar con nuestros clientes al ofrecer pruebas de diagnóstico y soporte técnico. Estoy confiado que el nuevo laboratorio nos permitirá optimizar las ofertas de nuestros productos existentes y tomar el desarrollo de productos a nuevas alturas”.

El laboratorio que lleva el nombre de Richard M. Jaffee, presidente de una compañía hermana de AMLAN, la corporación Oil-Dri de América. El espíritu y visión pionera de Oil-Dri para conducir las investigaciones de ciencias de vida han sido una influencia en el desarrollo de los productos de salud animal de valor añadido de AMLAN. Además, de las iniciativas que previamente discutimos, el laboratorio será usado por todas las facetas de negocios de Oil-Dri y su desarrollo como una inversión para el futuro de la compañía como un todo.

Contacto

Reagan Culbertson (312)702- 3256

Reagan.culbertson@AMLAN.com

Referente a AMLAN Internacional

Parte de la corporación Oil-Dri de América (NYSE: ODC), una empresa de Delaware cuyo nombre comercial es “AMLAN Internacional”, ha aumentado su oferta de productos al desarrollar nuevas moléculas para la salud intestinal, una alternativa de los AGP (antibióticos promotores de crecimiento) del mercado. El laboratorio del departamento de Investigación y Desarrollo está ubicado en Vernon Hills, IL. En el 2013, el alcance global de la compañía se expandió con el establecimiento de su subsidiaria China, en Shenzhen. Para más información sobre AMLAN Internacional, visite AMLAN.com.

 

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

La Dra. Margie Lee (UGA) habla en la reunión de ventas globales en Amlan Internacional en Chicago.

Posted on | by Chris Underdown

CHICAGO, IL.—Amlan Internacional, líder en la salud intestinal en la industria global de salud y nutrición animal anuncia que la Dra. Margie Lee, Profesora de Salud de Población y directora del Laboratorio de Diagnóstico, del Centro de Investigación y Diagnóstico Avícola y el Colegio de Medicina Veterinaria en la Universidad de Georgia, hablará en su reunión de ventas globales el miércoles 13 de septiembre. Su presentación se enfocará en la patogénesis bacteriana y mecanismos potenciales de las alternativas a antibióticos en la producción avícola.

La investigación de la Dra. Lee se enfoca sobre la epidemiología de la carne y seguridad alimentaria a patógenos de origen avícola, patogénesis microbiana, y ecología del microbioma intestinal aviario. Su investigación se ha presentado en 77 publicaciones revisada por pares, así como capítulos en el Manual Merck de Veterinaria y el Manual de Laboratorio para Aislamiento.

El Dr. Ron Cravens, presidente de Amlan Internacional, una corporación de Nevada declaró, “Estamos muy entusiasmados de tener a la Dra. Lee se dirija a nuestro equipo. Estoy confiado que su experiencia en la industria proveerá de ideas útiles para comunicarnos con nuestros clientes”.

Contacto

Reagan Culbertson (312)702- 3256

Reagan.culbertson@AMLAN.com

Referente a AMLAN Internacional

Parte de la corporación Oil-Dri de América (NYSE: ODC), una empresa de Delaware cuyo nombre comercial es “AMLAN Internacional”, ha aumentado su oferta de productos al desarrollar nuevas moléculas para la salud intestinal, una alternativa de los AGP (antibióticos promotores de crecimiento) del mercado. El laboratorio del departamento de Investigación y Desarrollo está ubicado en Vernon Hills, IL. En el 2013, el alcance global de la compañía se expandió con el establecimiento de su subsidiaria China, en Shenzhen. Para más información sobre AMLAN Internacional, visite AMLAN.com.

 

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Dr. Margie Lee (UGA) to Speak at Amlan International’s Global Sales Meeting in Chicago

Posted on | by Chris Underdown

CHICAGO, IL.— Amlan International, a leader in intestinal health in the global animal health and nutrition industry announces that Dr. Margie D. Lee, Professor of Population Health & Diagnostic Laboratory Director, Poultry Diagnostic and Research Center & College of Veterinary Medicine at The University of Georgia, will speak at their Global Sales Meeting on Wednesday, September 13th. Her presentation will focus on bacterial pathogenesis and potential mechanisms of antibiotic alternatives in poultry production.

Dr. Lee’s research is focused on epidemiology of meat and poultry-borne food safety pathogens, microbial pathogenesis, and ecology of poultry intestinal microbiome. Her research has been featured in 77 peer-reviewed publications as well as chapters in the Merck Veterinary Manual and the Laboratory Manual for Isolation.

Dr. Ron Cravens, President of Amlan International, a Nevada corporation, stated, “We are excited to have Dr. Lee address our team. I am confident that her industry experience will provide helpful insight in communicating with our customers.”

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Argentina’s Top Poultry Producers Visit Chicago for Insight on AGP Alternatives

Posted on | by Chris Underdown

Argentina’s Top Poultry Producers Visit Chicago for Insight on AGP Alternatives

CHICAGO—Argentina’s largest poultry producers and integrators recently traveled to Chicago to gain insight on current production practices and emerging solutions available from the U.S. market. The group, accompanied by representatives from Elanco, the biggest distributor of antibiotics in Argentina, attended a special presentation and discussion about Varium, a new non-antibiotic growth promoter from Amlan International. They also toured the Chicago Board of Trade and Chicago Mercantile Exchange, and gained insight on grain markets from Celina Mesquida, agricultural analyst at RJ O’Brien.

“The group had a lively discussion about trends in poultry production and the changing approach to antibiotic use,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation. “Our team was thrilled to share the results of our clinical studies, which show that Varium promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.”

Elanco serves as Amlan International’s distribution partner in Japan and most countries in Latin America.

###

About Amlan International

Oil-Dri Corporation of America, doing business as Amlan International, helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Adds Staff to Accommodate Growth in China

Posted on | by Chris Underdown

Amlan International Adds Staff to Accommodate Growth in China

SHENZHEN, CHINA—Amlan International announces the addition of three new hires to its China subsidiary, Amlan Trading (Shenzhen) Company, Ltd., keeping pace with growth due to expanding market penetration. The new sales managers were hired to increase service in different regions of China.

Mr. Jixin Dai has taken on the role of Sales Manager of South China. He has over 9 years of experience in the livestock industry, and holds a bachelor degree in Animal Science from China Agricultural University. Dai will help Amlan Trading develop new client relationships in South China while promoting product sales.

Mr. Shengguo Tang joins Amlan Trading as Sales Manager of Central China. Backed by 8 years of experience in the feed industry, Tang will work to further establish a distribution network and increase Amlan Trading’s market share in Central China. He previously held the position of Regional Sales Manager of Novus International Trading (Shanghai) Co, Ltd. and received his Master’s Degree of Animal Nutrition from Hu Nan Agriculture University.

Mr. Quingliang Wu will assume the role of Sales Manager of East China. After his work selling Biomin’s products in East China, Wu comes to Amlan Trading with over 5 years of sales experience in feed additive products. He will be responsible for promoting Amlan product sales in East China. Wu is a graduate of Shanxi Agricultural University with a major in Animal Science.

“We are proud to announce these strategic new hires to support our mission of providing personal technical service across South, Central, and East China,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation.

###

About Amlan International

Oil-Dri Corporation of America, doing business as Amlan International, helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Calibrin‐Z Gains OMRI Listed Status, Gives Organic Producers Access to Bacterial Toxin Binder

Posted on | by Chris Underdown

Calibrin‐Z Gains OMRI Listed Status, Gives Organic Producers Access to Bacterial Toxin Binder

CHICAGO, IL— Calibrin‐Z, which recently became the first product approved for the control of disease‐causing bacterial toxins, has gained listed status from the Organic Materials Review Institute (OMRI). This approval confirms the product can be used in certified organic production according to the USDA National Organic Program Rule.

Calibrin‐Z is a broad spectrum bacterial and fungal toxin adsorbent for use in livestock that has proven in more than 70 clinical studies to reduce effects from a broad spectrum of biotoxins that cause disease such as those produced by Clostridium perfringens, E. coli and Salmonella.

Recently completed work from the USDA demonstrates the ability of the product to control toxins produced by pathogenic bacteria, which are a leading source of economic loss to the global livestock industry.

“As the recently completed clinical research demonstrates, Calibrin‐Z is the only product to control the broadest range of bacterial and fungal toxins, which makes its OMRI Listed status extremely beneficial to organic and conventional producers alike,” said, Dr. Ron Cravens, President, Amlan International.

The Organic Materials Review Institute (OMRI) is a third party institute that provides organic certifiers, growers, manufacturers and suppliers with an independent review of products intended for use in certified organic production, handling and processing.

For more information on Calibrin‐Z, visit www.Amlan.com

###

Amlan International, a division of Oil‐Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube